In the treatment of PAs, recent studies reveal that fulvestrant significantly suppresses the cell viability and invasion of rat PA GH3 cells by simultaneous regulation of ERK1/2, JNK1/2, and p38 signaling pathways (27). Here, MAPK3 is linked to gonorrhea.